CTCarolina Bioni Garcia Teles

Carolina Bioni Garcia Teles

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Carolina Bioni Garcia Teles has a total of 86 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Incubation time to preserve Plasmodium vivax gametocyte infectivity in Anopheles darlingi

    by Najara Akira Costa dos Santos, Alice O. Andrade, Leandro N. Martinez, Amália S. Ferreira, Carolina B. G. Teles, Jansen Fernandes Medeiros, Maisa da Silva Araújo

    The gametocyte viability and infectivity of Plasmodium vivax in blood samples are crucial to assessing the efficacy of transmission-blocking (TB) strategies. However, contact-based TB assays or the pharmacodynamics of anti-gametocyte candidates often require specific pre-exposure to compounds prior to blood feeding assays. As suboptimal storage and prolonged exposure to host immune factors could impact gametocyte viability, it is important to determine the optimal timeframe for performing TB assays with the Direct Membrane Feeding Assay (DMFA). Here, we assessed three blood sample storage conditions to determine the maximum timeframe for maintaining experimental validity in DMFA. The incubations protocols tested preserved P. vivax gametocyte viability for up to three hours post-blood collection, maintaining robust infection prevalence and intensity. After six hours of post-blood collection, the decline in infectivity was significant across all three protocols, highlighting the need to optimize long-term storage to maintain accuracy for extended TB assays. These findings establish a reliable window for membrane feeding assays in experimental designs that need at least three hours for pre-exposure preparations.

  • Open Access

    Prospecção Tecnológica de Patentes sobre Extratos Vegetais para Leishmaniose Cutânea: lacunas e oportunidades de inovação

    by Aurileya de Jesus Gouveia, Maria Clara Camilo da Silva, Carolina Bioni Garcia Teles, Minelly Azevedo da Silva

    A leishmaniose cutânea (LC) é uma doença negligenciada com elevada incidência no Brasil, e a biodiversidade representa fonte pouco explorada para terapias inovadoras. Apesar da relevância epidemiológica e dos avanços com extratos vegetais, existe uma lacuna entre a produção científica e a proteção intelectual, refletida no baixo número de patentes, sobretudo nacionais. Este estudo objetivou: (i) mapear patentes sobre extratos vegetais no tratamento da LC; (ii) identificar lacunas tecnológicas e oportunidades de inovação; e (iii) propor estratégias para fortalecer a proteção intelectual de ativos naturais. A metodologia consistiu em prospecção tecnológica nas bases INPI, Espacenet e Patentscope (2008-2025), com descritores e códigos IPC/CPC. As patentes foram triadas por relevância terapêutica, exclusão de duplicatas e categorização. Foram identificadas 18 patentes, três no INPI, com predominância de formulações tópicas. Os resultados evidenciam descompasso entre produção acadêmica e proteção intelectual, além da sub-representação da biodiversidade brasileira, reforçando a importância de políticas integradas.

  • Open Access

    Epidemiological surveillance of canine visceral leishmaniasis in a municipality in the Western Amazon

    by Amanda Carolina Barbosa de Aguiar, Leormando Fortunato Dornelas Júnior, Eric Fabrício Marialva, Andre de Abreu Rangel Aguirre, Claudia María Ríos Velásquez, Felipe Arley Costa Pessoa, Hemelly Suldini da Silva, Carolina Bioni Garcia Teles, Amália dos Santos Ferreira, Raiane Gosenheimer Peruffo, et al.

    Visceral leishmaniasis is a zoonotic disease of public health importance in Brazil, with expansion into peri-urban areas. This cross-sectional study evaluated 450 dogs in a municipality of the Western Amazon, Brazil, using TR-DPP® serology, ELISA confirmation, hematological analysis, PCR targeting the Hsp70 gene, and entomological surveys with CDC light traps. A total of 45 dogs (10%) were seroreactive, and 34 were confirmed by ELISA. Hemoparasites such as Babesia spp. were detected. All pooled samples were negative by PCR. Six species of phlebotomine sand flies were identified, including Nyssomyia antunesi and Migonemyia migonei. The findings suggest early exposure of dogs in an area of emerging epidemiological risk, highlighting the importance of integrated surveillance strategies.

  • Open Access

    Use of latex microbeads for detection of Plasmodium vivax lactate dehydrogenase using flow cytometry

    by A.M.F. Franco, J.C. Glória, Y.O. Chaves, A.S. Ferreira, C.B.G. Teles, A.A.S. Balieiro, W.L.L. Neves, L.P. de Sousa, J.D.N. Costa, P.A. Nogueira, et al.

    Malaria is a parasitic disease of great relevance in global public health. The development of new sensitive and specific diagnostic high-throughput methods remains a challenge in the eradication of this disease. In this study, we developed a flow cytometry test using latex microbeads and polyclonal antibodies obtained from rabbits and mice for the detection of the P. vivax lactate dehydrogenase (PvLDH) antigen. We processed 50 samples from Brazilian patients diagnosed with malaria caused by P. vivax and 40 samples from healthy individuals. The assay presented sensitivity of 64%, specificity of 97%, a positive predictive value of 97%, and a negative predictive value of 57% when analyzed using the fluorescent labeling method. Using the mean fluorescence intensity (MFI) analysis method, the sensitivity was 53%, specificity was 89%, the positive predictive value was 95%, and the negative predictive value was 33%. In both methods of analysis, we observed significant statistical differences between the analyzed groups (P-value <0.0001). A high correlation (0.60) between the two methods and a low correlation between PvLDH concentration and parasite density was found. The test was able to detect the PvLDH protein with high specificity, but its sensitivity should be improved. More promising results were observed when the samples were analyzed according to the percentage of fluorescent labeling. Improvement of this assay would enable its application as a serological test for the detection of asymptomatic patients and for the validation of rapid diagnostic tests.

  • Open Access

    Cytotoxicity Evaluation and Dereplication of Flavonoids-Guided by Antioxidant Activity and Total Phenolics Content from Ephedrantus amazonicus Leaves

    by Alisson Martins Albino, Débora Luciano Gomes, Arthur Henrique dos Santos, Giovanna de Souza Lima Malta, David Henrique Lima de Oliveira, Luís Fernando Lira Souto, Carolina Bioni Garcia Teles, Saara Neri Fialho, Minelly Azevedo da Silva, Nilton Fagner de Oliveira Araújo, et al.

    Plants synthesize secondary metabolites as a means of survival and competition. These metabolites are a potential source of natural antioxidants that may promote activity, favoring the control of cellular damage caused by oxidative stress. The Annonaceae family occurs in tropical and subtropical regions worldwide. The medicinal benefits of plants from this family are caused by secondary metabolites present in these species. Thus, this study aimed to determine the total phenolic content, evaluate the antioxidant potential, and in vitro cytotoxicity of the leaf ethanolic extract from Ephedrantus amazonicus R. E. Fries. The phenolic content and antioxidant activity were evaluated by the Folin-Ciocalteu and DPPH methods, respectively. The assays were adapted for 96-well microplates, with absorbance reading at λ = 630 and 517 nm, respectively, using a UV-Vis spectrophotometer. The in vitro cytotoxicity assay was performed using fibroblasts (L929 cell line). The MS/MS analyses were performed through direct infusion using a LCQ Fleet mass spectrometer equipped with APCI font and ion trap analyzer, in the positive and negative mode. A molecular network was created using the online workflow on the GNPS website (http://gnps.ucsd.edu). The phenolic content at 400μg was 25.24 ± 0.98μg.GAE/g, while the antioxidant activity showed an EC50 of 13.37±2.63 μg.mL-1. Dereplication led to the annotation of three flavonoids that may contribute to the observed antioxidant activity. The extract showed low cytotoxicity at the highest tested concentration (> 500μM). The results demonstrate that the extract from Ephedrantus amazonicus R.E. Fries leaves is a promising source of natural antioxidants.


  • Open Access

    Pharmacokinetic Profile of a Drug Repurposing Candidate for the Treatment of Cutaneous Leishmaniasis (in Silico)

    by Arlindo Gonzaga Branco Junior, Nilton Fagner de Oliveira Araújo, Saara Neri Fialho, Minelly Azevedo da Silva, Carolina Bioni Garcia Teles

    The calculated or experimental physical-chemical Properties are important for choosing substances that will be used in the treatment of several diseases by different administration routes. Chloroquine, for example, is a drug with several biological activities that has been constantly investigated as an alternative to drug repurposing in different diseases. With respect to leishmaniasis, there are few treatment options, which are invasive and have several adverse effects. Another point is the identification of important drug molecular targets, understand their functions, and thus discovering new therapeutic alternatives. Thus, this work aimed at: performing an in analysis of the pharmacokinetic profile of chloroquine as an option for the treatment of cutaneous leishmaniasis by dermal route; evaluating the interaction of the drug with the enzyme Trypanothione reductase, responsible for the parasite’s redox balance. The melting point was obtained in the PUBCHEM database. Analysis showed that chloroquine presented a partition coefficient, molecular weight, and melting point within the established proper range of parameters. The skin permeability coefficient also presented a satisfactory value, as well as the values for total polar surface area, number of rotatable bonds, and sp3 Carbon Fraction. In molecular docking simulations, chloroquine showed interactions with the enzyme TRLb, with a calculated Ki lower than that of the reference compound. This study reinforces the theoretical prediction and good solubility and permeability of chloroquine. The results justify further investigations on the inhibition of TRLb as an important alternative for the treatment of leishmaniasis.

  • Synthesis of New Bi-Triazoles with Plasmocide Action Against Plasmodium falciparum

    by Dinesh Addla, Cristiane Diniz, Quelli Larissa Oliveira de Santana, Leandro Do Nascimento Martinez, Marcinete Latorre Almeida, Minelly Azevedo da Silva, Welington da Silva Paula Do Nascimento, Aurileya de Jesus Gouveia, Saara Neri Fialho, Amália dos Santos Ferreira, et al.

    Background: A series of bi-triazoles conjugates 1,2,3 and 1,2,4 was synthesized with an aim to study the evaluation of the antimalarial profile of families of triazole derivatives. The study used the W2 strain of Plasmodium falciparum (Chloroquine-Resistant), to determine the inhibitory concentration of 50% of the parasites (IC50) and HepG2 cells to describe the cytotoxic concentration for 50% of the cells (CC50). Among the study classes, bi-triazoles stood out with IC50 values between 8.9 to 0.45 μM; highlighted the compound 14d (IC50 of 0.45 ± 0.02 μM) with the most promising result. Regarding the cytotoxic concentration, all compounds that presented IC50 values ≤ 100 μM were evaluated. Three compounds stood out as the highest selectivity index (SI) values, 14b (SI ˃111.1), 13d (SI ˃111.1) and 14d (SI ˃1.111). Such results expose the importance of working with classes of molecules that allow rapid synthesis and dispositions for structural changes. Highlighting the evolution of the IC50 values of the compounds, when adding the second triazole block. Thus, the results found in this study, have the possibility of choosing new molecules for the treatment of malaria. Objective: This work was to synthesize a series of bi-triazole conjugates 1,2,3 and 1,2,4-triazole moiety and evaluate their activities against Plasmodium falciparum. Methods: The bi-triazole was synthesized in a 3-step route in moderated yields, and their structures were confirmed by NMR spectral data analyses. For the in vitro antiplasmodial assays, the SYBR Green fluorimetric technique and the W2 strain were used, where an IC50 (Inhibitory Concentration) value was obtained for each compound. The compounds were also evaluated for their stagespecificity and speed of action (W2 strain). Safety tests were performed to determine the hemolytic and cytotoxic action of the evaluated compounds. In these tests, the cell lines HepG2 and VERO were used, and the cytotoxicity was evaluated by the MTT technique. This allowed the CC50 values to be obtained (Cytotoxic Concentration). Subsequently, the Selectivity Index (SI) was calculated for each compound. Results: The newly synthesized bi-triazole compounds could serve as potent leads for the development of novel antimalarial compounds. In general, the bi-triazoles with trifluoromethyl group present at 1,2,4-triazole moiety proved to be more potent regarding antiplasmodial activity. Conclusion: The synthesized bi-triazole compounds could serve as potent leads for the development of novel antimalarial agents.


  • Open Access

    Screening in vitro e in silico de amidas contra as formas sexuadas do Plasmodium falciparum

    by Minelly Azevedo da Silva, Leandro Do Nascimento Martinez, Marcinete Latorre Almeida, Amália dos Santos Ferreira, Saara Neri Fialho, Harold Hilarion Fokoue, Massuo Jorge Kato, Maisa da Silva Araújo, Carolina Bioni Garcia Teles

    Objective: To evaluate the activity of these compounds on sexual forms of Plasmodium falciparum and to determine the theoretical pharmacokinetic properties of the compounds using in silico assays. Methods: In order to evaluate the inhibition of exflagellant forms, Plasmodium falciparum strain NF54 was used for the production of gametocytes in vitro. The program ADMETlab was used in in silico tests to identify the theoretical pharmacokinetic properties of all compounds. Results: A number of tested natural and synthetic amides do not stand out as possible blockers of malaria transmission. However, they showed moderate inhibition in blocking exflagellation. The results of the virtual screening allowed to know and explore interesting theoretical pharmacokinetic properties of this class of compounds, such as moderate permeability with Caco-2 cells of compound 14f; all can be harmful but non-lethal (LD50); only compound 14f can cause damage to some food (LHID); compounds 1a, 1b, 1g and 1k can be administered at their daily maximum, always noting, 1g and 1k can be administered at their daily maximum; low throughput (CL); high plasma protein binding for compounds 1a, 14f and 18a; optimal distribution volume for 1b, 1g, 1k, 18a and 18b. Final considerations: The results obtained contribute to expand the database on the profile of this class of compounds and antimalarial action.

  • Open Access

    A utilização de Artesunato e Cloroquina como alternativa terapêutica para tratamento de Leishmaniose tegumentar americana: uma revisão

    by Arlindo Gonzaga Branco Junior, Ítalo Diógenes Gomes da Silva, Saara Neri Fialho, Marcinete Latorre Almeida, Leandro Do Nascimento Martinez, Norton Rubens Diunior Lucas Pejara Rossi, Minelly Azevedo da Silva, Carolina Bioni Garcia Teles

    Objective: To carry out a review of studies published between 2016 and 2021 focusing on the treatment of Leishmaniasis with the drugs Artesunate and Chloroquine. Methods: This is an integrative literature review that was produced using the following steps: identification of the theme, formulation of the guiding question, definition of descriptors and selection of databases, establishment of exclusion and inclusion criteria of the studies, sampling of the literature and pre-selection of articles (reading of abstracts and titles); reading of the selected studies and, finally, interpretation of the results. Results: 134 studies were found for the drug Artesunate, 2 of which were included in this research and show the effectiveness of treatment with Artesunate in in vitro experiments against the species Leishmania amazonensis, L. tropica, L. infantum and L. donovani, as well as in in vivo assays against L. amazonensis. For the drug Chloroquine, 11 articles were found, 3 of which were included in the present study. Of these, two studies evaluated the action of this drug in human trials through intralesional and oral administration, and one evaluated its activity in vitro and in vivo against L. amazonensis. Final considerations: This article highlights studies that present Artesunate and Chloroquine as promising drugs for the treatment of Leishmaniasis. The low number of studies suggests the need for further investigations with in vivo tests and new forms of treatment (topical use) for the lesions.


  • Natural and Semisynthetic Triterpenes from Combretum leprosum Mart. with Antiplasmodial Activity

    by Guilherme Passarini, Amália Ferreira, Leandro Moreira-Dill, Fernando Zanchi, Aurileya de Jesus, Valdir Facundo, Carolina Teles

    Malaria is responsible for thousands of deaths each year. Currently, artemisinin combination therapy (ACT) is used as first-choice medication against the disease. However, the emergence of resistant strains prompts the search for alternative compounds. The present study aimed to investigate the antiplasmodial activities of natural triterpenes (compounds 1 and 2), and semisynthetic derivatives 1a, 1b, 1c, and 1d. Antiplasmodial assays were carried out using the SYBR Green technique, whereas cytotoxicity was evaluated by the MTT (3-(4,5-dimethylthiazol- 2-yl)-2,5-diphenyltetrazolium bromide) method. Hemolytic assays were performed on human erythrocytes. An in silico analysis of the compounds against PfENR (Plasmodium falciparum 2-trans-enoyl-reductase) was carried out by molecular docking. Experiments with 1, and its derivatives against P. falciparum showed that 1a was very similar in terms of biological activity to compound 1 (half maximal inhibitory concentration (IC50) ca. 4 μM), whereas 1b, 1c, and 1d had reduced antiplasmodial activities (IC50 between 8-103 μM). The selectivity indexes of 1 and 1d for HepG2, and Vero cells were > 10. Docking results partially agreed with the in vitro experiments, with 1 and 1c having the best and worst affinities with PfENR, respectively. In conclusion, the results showed that 1 and 1d may serve as biotechnological tools in the development of antimalarial drugs.